Amanta Healthcare, a pharmaceutical company specialising in sterile parenteral products, has raised ₹37.8 crore from six institutional investors through its anchor book on August 29, ahead of its initial public offering (IPO).
The IPO, worth ₹126 crore, comprises a fresh issue of 1 crore shares and will open for public subscription on September 1 and close on September 3. The company will finalise share allotment on September 4, with listing scheduled for September 9.
Anchor Investor Allocation
Amanta Healthcare said it allotted 30 lakh shares to anchor investors at the upper end of the price band, ₹126 per share.
- Bandhan Mutual Fund: 7.93 lakh shares via its Small Cap Fund
- Other investors: Sanshi Fund, Perpetuity Health to Wealth Rising Fund, Sunrise Investment Trust, and Finavenue Capital Trust
IPO Utilisation of Funds
The company, seeking a valuation of nearly ₹500 crore, plans to deploy the proceeds as follows:
- ₹70 crore: Setting up a new SteriPort manufacturing line
- ₹30.13 crore: New small volume parenteral (SVP) unit at Hariyala, Gujarat
- Remaining funds: General corporate purposes
Lead Manager
Beeline Capital Advisors is the sole book-running lead manager for the IPO.
